850101P

13:0 Lyso PI

1-tridecanoyl-2-hydroxy-sn-glycero-3-phospho-(1′-myo-inositol) (ammonium salt), powder

• 別名: PI(13:0/0:0); 110716
• 実験式（ヒル表記法）: C₂₂H₄₆NO₁₂P
• CAS番号: 1246430-02-3
• 分子量: 547.57
• UNSPSCコード: 51191904
• NACRES: NA.25

特性

• アッセイ: >99% (LPI; may contain up to 10% of the 2-LPI isomer, TLC)
• 形状: powder
• 包装: pkg of 1 × 100 μg (with stopper and crimp cap (850101P-100ug)); pkg of 1 × 500 μg (with stopper and crimp cap (850101P-500ug))
• メーカー／製品名: Avanti Research^™ - A Croda Brand 850101P
• 脂質タイプ: phospholipids; cardiolipins
• 輸送温度: dry ice
• 保管温度: −20°C
• SMILES記法: [H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O)=O)(O)COC(CCCCCCCCCCCC)=O.[NH4+]

詳細

詳細

Lysophosphatidylinositol (LPI), produced by phospholipase A2 is a bioactive lipid.

アプリケーション

13:0 Lyso PI (1-tridecanoyl-2-hydroxy-sn-glycero-3-phospho-(1′-myo-inositol) may be used as a nonendogenous phospholipid (PL) standard for the quantitative analysis of PLs. It may also be used as a standard for tandem mass spectrometry analysis of lipid species in human plasma.

生物化学的／生理学的作用

Increased circulating levels of L-alpha-lysophosphatidylinositol (LPI) are associated with cancer and LPI is a potent ligand for the G-protein-coupled receptor GPR55.

Lysophosphatidylinositol (LPI) is expected to play a vital role in various diseases. Ca²⁺ channels at the plasma membrane and mitochondrial membrane are controlled by LPI. It can also stimulate various signaling pathways to control several cellular processes. LPI can block the migration of cells.

包装

2 mL Amber Serum Vial with Stopper and Crimp Cap (850101P-100ug)

2 mL Amber Serum Vial with Stopper and Crimp Cap (850101P-500ug)

法的情報

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全性情報

• 保管分類コード: 11 - Combustible Solids